C225 anti-epidermal growth factor receptor (EGFR) monoclonal antibody sensitizes human non-small cell lung cancer to both radiation and chemotherapy cytotoxicity in-vitro and in-vivo

@inproceedings{Helfrich2001C225AG,
  title={C225 anti-epidermal growth factor receptor (EGFR) monoclonal antibody sensitizes human non-small cell lung cancer to both radiation and chemotherapy cytotoxicity in-vitro and in-vivo},
  author={Barbara Helfrich and David Raben and Daniel C. F. Chan and Leyre Rueda Garc{\'i}a and T. Shogun and Wayne Zundel and Fred R Hirsch and Wilbur Alan Franklin and Paul P.A. Bunn},
  year={2001}
}